The head of an Irish pharmaceutical firm says Donald Trump's tariff plan will spike medicine costs and put lives at risk in the US.
The American President says he will be introducing tariffs on pharmaceuticals - specifically citing Ireland among the countries where many pharmaceutical products are made.
He said this would bring production back to the US claiming, "We don't make anything" domestically.
The CEO of Nutriband, Gareth Sheridan says this will cost lives in the United States.